• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Preclinical CRO Companies

    ID: MRFR/HS/5807-CR
    200 Pages
    Rahul Gotadki
    April 2025

    Preclinical Contract Research Organizations (CROs) are specialized companies that provide a wide range of research services to pharmaceutical, biotechnology, and medical device companies during the preclinical phase of drug development. This phase involves extensive testing and research before a potential drug or medical device can advance to clinical trials.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Preclinical CRO Market Research Report - Forecast till 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Preclinical CRO Market


    Preclinical CRO Key Companies*Disclaimer: List of key companies in no particular orderLatest Preclinical CRO Companies Update


    • Jun 2023:The estimated annual earnings of Laboratory Corp of America Holdings (LH.N) have decreased since the separation of its clinical development company, Fortrea. The lab owner has been struggling with a shortage of lab monkeys because of limitations on animal imports after a Cambodian supplier was accused of smuggling animals into the US. However, the company expects supply problems with non-human primates (NHPs) to be resolved in the third quarter. In addition, the business now expects core operations revenue to expand by 11.3% to 12.6% for the year rather than the initial projection of 9.5% to 11%. The company predicts that COVID testing revenues will fall by 85% to 89% this year compared to its earlier forecast




    • Sep 2023: The next-generation Clinical Trial Tokenization technology is now available, according to ICON plc, a pioneer in clinical research and healthcare information. ICON's innovative tokenization engine, real-world data access, and advanced clinical analytics know-how offer priceless, long-term therapeutic efficacy and safety insights over the product development lifecycle. Now that operational models are united and smooth, all these aspects are delivered. ICON's next-generation patented Clinical Trial Tokenisation system seamlessly integrates all the necessary components and makes collecting patient data in a covert, consent-based, and non-intrusive way possible. This is made possible by Privacy Protected Record Linkage (PPRL) across time and source. Advanced algorithms and ICON's ability to create multiple tokens enable very accurate (up to 90%) matching of clinical trial participants to the largest ecosystem of real-world data sources in the United States.


    List of Preclinical CRO Key companies in the market

    • IQVIA (U.S.),

    • PAREXEL International Corporation (U.S.),

    • Envigo (U.S.),

    • Charles River (U.S.),

    • Eurofins Scientific (Luxembourg),

    • ICON PLC (Dublin),

    • PRA Health Sciences (U.S.),

    • Medpace (U.S.),

    • Laboratory Corporation of America Holdings (U.S.),

    • Pharmaceutical Product Development, LLC (U.S.),

    • WuXi AppTec (China)

    • D. Biosciences (U.S.)